Krüger H U, Schuler U, Proksch B, Göbel M, Ehninger G
Department of Internal Medicine II, University Hospital Tübingen, Federal Republic of Germany.
Antimicrob Agents Chemother. 1990 Jun;34(6):1048-52. doi: 10.1128/AAC.34.6.1048.
The effect of the 4-quinolone antimicrobial agent ciprofloxacin on the concentration in plasma and the pharmacokinetics of the immunosuppressive agent cyclosporine was studied in 10 bone marrow transplant recipients. There were no statistically or clinically significant changes in cyclosporine trough concentrations or areas under the concentration-time curve following oral doses of 500 mg of ciprofloxacin every 12 h for 4 days. The data suggest a lack of relevant pharmacokinetic interaction of ciprofloxacin with cyclosporine. There was no indication of an enhanced nephrotoxicity for this drug combination.
在10名骨髓移植受者中研究了4-喹诺酮类抗菌药物环丙沙星对免疫抑制剂环孢素血浆浓度及药代动力学的影响。每12小时口服500mg环丙沙星,持续4天,之后环孢素的谷浓度或浓度-时间曲线下面积没有统计学或临床意义上的显著变化。数据表明环丙沙星与环孢素之间缺乏相关的药代动力学相互作用。没有迹象表明该药物组合的肾毒性增强。